Call us any time +86 138-**** ****

Platform Information

+ 420 7700 1007 [email protected]

Study Results from Kansai Medical University Update Understanding of Cerebrovascular Disease (Cardiovascular Safety of Romosozumab Versus Other Anti-Osteoporosis Medications in Patients with Osteoporosis: A Nationwide Health Insurance Claim - 世界杯2026

Official World Cup Insights

At 世界杯官网, we believe football's allure extends far beyond the pitch—it is a vessel that unites global passion and transmits dreams.

  • Home
  • Event Details

来自日本大阪的消息,关西医科大学的研究公布了关于脑血管疾病的新结果。

该研究着重探讨了罗莫司尤单抗(Romosozumab, Rmab)——一种具有双重作用(抑制骨吸收和促进骨形成)的强效抗骨质疏松药物——的心血管安全性。研究人员利用了日本全国健康保险索赔数据库,对罗莫司尤单抗与其他抗骨质疏松药物(AOMs)在患者中的心血管疾病(CVD)发病率进行了比较。

根据研究提供的数据,与甲状旁腺激素(PTH)相比,在男性患者中,使用罗莫司尤单抗的调整后风险比(HRs)显示:急性心肌梗死的风险比为0.49,缺血性心脏病的风险比为0.59,脑血管疾病的风险比为0.70。

这项研究的详细信息可在《Cardiovascular Safety of Romosozumab Versus Other Anti-Osteoporosis Medications in Patients with Osteoporosis: A Nationwide Health Insurance Claims Database Study in Japan》中找到。

Search

Service List

  • Custom Events
  • Global Events
  • Design & Build
  • Data Integration Specialist
  • Sustainable Events

Popular Articles

  • Live Scores 2026世界杯官网 delivers real-time match results with zero delay, keeping you at the heart of every goal.
  • Team Analysis In-depth tactical breakdowns of top contenders, powered by 世界杯官网 expert data for informed fan insights.
  • Schedule Hub Access the complete 2026 World Cup fixture list on 世界杯官网, with match times and venue details at a glance.

Hot Tags

  • Match Focus
  • Modern Events
  • Smart Events
  • Innovative Events
  • Event Trends
  • Tech Frontier